<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR25">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ishiguro</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Misu</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Iwasa</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Izawa</surname>
    <given-names>T</given-names>
   </name>
  </person-group>
  <article-title>Analysis of safety-related regulatory actions by Japanâ€™s pharmaceutical regulatory agency</article-title>
  <source>Pharmacoepidemiol Drug Saf.</source>
  <year>2017</year>
  <volume>26</volume>
  <issue>11</issue>
  <fpage>1314</fpage>
  <lpage>1320</lpage>
  <pub-id pub-id-type="doi">10.1002/pds.4252</pub-id>
  <?supplied-pmid 28722235?>
  <pub-id pub-id-type="pmid">28722235</pub-id>
 </element-citation>
</ref>
